Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$920K Sell
10,140
-423
-4% -$38.6K 0.02% 280
2026
Q1
$1.08M Sell
10,563
-12,779
-55% -$1.44M 0.02% 227
2025
Q4
$2.92M Buy
23,342
+307
+1% +$39.1K 0.06% 132
2025
Q3
$3.08M Sell
23,035
-761
-3% -$99.9K 0.07% 131
2025
Q2
$3.2M Buy
23,796
+2,860
+14% +$377K 0.08% 127
2025
Q1
$2.78M Sell
20,936
-8,033
-28% -$1.02M 0.07% 119
2024
Q4
$3.29M Buy
28,969
+3,267
+13% +$378K 0.08% 112
2024
Q3
$2.93M Sell
25,702
-3,902
-13% -$428K 0.07% 125
2024
Q2
$3.08M Sell
29,604
-3,872
-12% -$411K 0.08% 115
2024
Q1
$3.65M Buy
33,476
+3,739
+13% +$429K 0.1% 106
2023
Q4
$3.27M Buy
+29,737
New +$2.97M 0.1% 96

Other funds holding ABT

AlTi Global's ABT Position: Q2 2026 in Review

AlTi Global reduced its Abbott (ABT) stake by 4% in Q2 2026, selling an estimated $38.6K and leaving 10,140 shares worth $920K. The position accounts for 0.02% of the portfolio, ranked #280.

AlTi Global first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.65M in Q1 2024. 1,892 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • AlTi Global held 10,140 shares of Abbott worth $920K as of Q2 2026.
  • AlTi Global sold 423 Abbott shares in Q2 2026, an estimated $38.6K.
  • Abbott made up 0.02% of AlTi Global's portfolio in Q2 2026, its #280 holding.
  • AlTi Global first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • AlTi Global's Abbott position peaked at $3.65M in Q1 2024.
  • 1,892 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on AlTi Global's 13F filing for Q2 2026, filed 5 Aug 2026.